Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INTT NASDAQ:NAUT NASDAQ:PRE NASDAQ:PRPO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINTTinTEST$7.28+1.7%$7.19$5.24▼$9.77$90.84M1.5837,935 shs21,298 shsNAUTNautilus Biotechnology$0.72+2.1%$0.73$0.62▼$3.09$91.03M1.42238,015 shs280,945 shsPREPrenetics Global$10.07+13.7%$8.03$3.09▼$11.99$115.05M0.1561,294 shs221,919 shsPRPOPrecipio$19.50-3.6%$15.34$3.90▼$22.38$32.76M1.0916,840 shs30,995 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINTTinTEST0.00%+0.14%+0.69%+6.59%+4.60%NAUTNautilus Biotechnology0.00%+9.03%-0.15%+2.81%-73.79%PREPrenetics Global0.00%+24.47%+30.95%+43.65%+112.00%PRPOPrecipio0.00%+9.92%+32.56%+79.72%+217.07%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINTTinTEST$7.28+1.7%$7.19$5.24▼$9.77$90.84M1.5837,935 shs21,298 shsNAUTNautilus Biotechnology$0.72+2.1%$0.73$0.62▼$3.09$91.03M1.42238,015 shs280,945 shsPREPrenetics Global$10.07+13.7%$8.03$3.09▼$11.99$115.05M0.1561,294 shs221,919 shsPRPOPrecipio$19.50-3.6%$15.34$3.90▼$22.38$32.76M1.0916,840 shs30,995 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINTTinTEST0.00%+0.14%+0.69%+6.59%+4.60%NAUTNautilus Biotechnology0.00%+9.03%-0.15%+2.81%-73.79%PREPrenetics Global0.00%+24.47%+30.95%+43.65%+112.00%PRPOPrecipio0.00%+9.92%+32.56%+79.72%+217.07%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINTTinTEST 2.67Moderate Buy$12.0064.84% UpsideNAUTNautilus Biotechnology 1.00Sell$2.13194.85% UpsidePREPrenetics Global 3.00Buy$9.00-10.63% DownsidePRPOPrecipio 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINTTinTEST$121.64M0.75$1.27 per share5.75$7.92 per share0.92NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/APREPrenetics Global$30.62M4.27N/AN/A$13.20 per share0.76PRPOPrecipio$18.53M1.70N/AN/A$8.16 per share2.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINTTinTEST$9.34M-$0.0731.6518.20N/A2.33%5.31%3.42%N/ANAUTNautilus Biotechnology-$70.78M-$0.52N/AN/AN/AN/A-32.53%-27.85%11/4/2025 (Estimated)PREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%10/6/2025 (Estimated)PRPOPrecipio-$4.29M-$1.19N/A∞N/A-8.48%-15.00%-10.21%11/5/2025 (Estimated)Latest PRPO, PRE, INTT, and NAUT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/6/2025N/APREPrenetics Global-$0.71N/AN/AN/A$21.70 millionN/A9/12/2025Q2 2025PREPrenetics GlobalN/A-$0.82N/A-$0.94N/A$17.68 million8/13/2025Q2 2025PRPOPrecipioN/A$0.05N/A$0.05N/A$5.65 million7/31/2025Q2 2025NAUTNautilus Biotechnology-$0.14-$0.12+$0.02-$0.12N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINTTinTESTN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/APRPOPrecipioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINTTinTEST0.082.261.38NAUTNautilus BiotechnologyN/A18.5218.52PREPrenetics GlobalN/A2.071.89PRPOPrecipio0.050.930.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINTTinTEST63.18%NAUTNautilus Biotechnology50.71%PREPrenetics Global25.01%PRPOPrecipio10.45%Insider OwnershipCompanyInsider OwnershipINTTinTEST7.00%NAUTNautilus Biotechnology41.10%PREPrenetics Global7.80%PRPOPrecipio16.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINTTinTEST32012.48 million11.69 millionOptionableNAUTNautilus Biotechnology130126.31 million74.39 millionOptionablePREPrenetics Global112.98 million11.97 millionNot OptionablePRPOPrecipio601.62 million1.35 millionNo DataPRPO, PRE, INTT, and NAUT HeadlinesRecent News About These CompaniesPrecipio Ends ATM Agreement with Alliance GlobalSeptember 4, 2025 | msn.comPrecipio Terminates Its ATMSeptember 2, 2025 | markets.businessinsider.comPrecipio, Inc. Terminates ATM Agreement with Alliance Global Partners to Strengthen Financial PositionSeptember 2, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comPrecipio Reports Improved Earnings Amidst Ongoing ChallengesAugust 16, 2025 | msn.comPrecipio, Inc. (PRPO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comPrecipio, Inc.: Precipio Announces its Q2-2025 Financial ResultsAugust 14, 2025 | finanznachrichten.dePrecipio, Inc. Reports Q2-2025 Financial Results Highlighting Revenue Growth and Improved Cash FlowAugust 13, 2025 | quiverquant.comQPrecipio Announces its Q2-2025 Financial ResultsAugust 13, 2025 | globenewswire.comPrecipio Announces Q2-2025 Shareholder Update CallJuly 31, 2025 | globenewswire.comPrecipio Enters Into Agreement With Warrant Holder To Exercise Majority ...July 13, 2025 | manilatimes.netMPrecipio amends warrant agreement, to receive $1.2M in cashJuly 13, 2025 | investing.comPrecipio, Inc. Modifies Warrant Structure to Reduce Share Dilution and Secure $1.2 Million Cash InflowJuly 11, 2025 | quiverquant.comQPrecipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As CashlessJuly 11, 2025 | globenewswire.comPrecipio, Inc. Urges Shareholders to Vote by 11 PM Today for Quorum at Upcoming MeetingJune 16, 2025 | quiverquant.comQPrecipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg Buys 1,399 SharesMay 31, 2025 | insidertrades.comInsider Buying: Precipio, Inc. (NASDAQ:PRPO) Director Purchases 8,035 Shares of StockMay 23, 2025 | insidertrades.comPrecipio, Inc. (NASDAQ:PRPO) Director Purchases $36,005.97 in StockMay 22, 2025 | insidertrades.comPrecipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comPrecipio, Inc.: Precipio Announces its Q1-2025 Financial ResultsMay 15, 2025 | finanznachrichten.deMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Eyes on the Sky: AST SpaceMobile Prepares for Commercial LaunchBy Jordan Chussler | September 8, 2025D-Wave Buying Spree: Will These Firms Be Potential Targets?By Nathan Reiff | August 19, 20253 Tariff-Proof Retailers Making New All-time HighsBy Dan Schmidt | September 1, 2025Is Viking’s Growth Still Worth the Premium?By Chris Markoch | August 20, 2025PRPO, PRE, INTT, and NAUT Company DescriptionsinTEST NYSE:INTT$7.28 +0.12 (+1.68%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$7.24 -0.04 (-0.48%) As of 09/12/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.Nautilus Biotechnology NASDAQ:NAUT$0.72 +0.01 (+2.05%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.72 0.00 (-0.51%) As of 09/12/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Prenetics Global NASDAQ:PRE$10.07 +1.21 (+13.66%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$10.15 +0.08 (+0.79%) As of 09/12/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Precipio NASDAQ:PRPO$19.50 -0.73 (-3.61%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$19.42 -0.09 (-0.44%) As of 09/12/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
